Maleic Acid

Maleic Acid

SCHEMBL1062042

CN.O=C(O)/C=C\C(=O)O

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2BTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3MPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PPARGSLC6A2SLC6A3SLC6A4SMOTYK2pol

The experimentally established mechanism targets of Maleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.75
TP53 P04637 1/20 0.75
EGLN1 Q9GZT9 1/20 0.75
EGLN3 Q9H6Z9 1/20 0.75
HCAR2 Q8TDS4 5/20 0.53
GABRP O00591 2/20 0.50
GABRD O14764 2/20 0.50
GABRA1 P14867 2/20 0.50
GABRB1 P18505 2/20 0.50
GABRG2 P18507 2/20 0.50
GABRB3 P28472 2/20 0.50
GABRA5 P31644 2/20 0.50
GABRA3 P34903 2/20 0.50
GABRA2 P47869 2/20 0.50
GABRB2 P47870 2/20 0.50
GABRA4 P48169 2/20 0.50
GABRE P78334 2/20 0.50
GABRA6 Q16445 2/20 0.50
GABRG1 Q8N1C3 2/20 0.50
GABRG3 Q99928 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL5874224 1.00 TSHR (0.75) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL5076417 1.00 TSHR (0.75) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL5318712 1.00 TSHR (0.75) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL1062045 1.00 TSHR (0.75) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL5874229 1.00 TSHR (0.75) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL2223143 0.87 TSHR (0.82) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL1924596 0.87 TSHR (0.82) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL9261130 0.87 TSHR (0.82) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL554796 0.87 TSHR (0.82) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL11284804 0.87 TSHR (0.82) TSHRTP53EGLN1EGLN3HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 237 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964827-B1 VENTILATION INSERT FREUDENBERG CARL KG (DE) 2019-11-06 EP claimed
CN-105026638-A Vane arrangement having alternating vanes with different trailing edge profile ELLIOTT CO 2015-11-04 CN claimed
CN-101013080-B Sheath liquid for particle analyzer, method of preparing sheath liquid and particle analytic method using the sheath liquid SYSMEX CORP 2012-12-12 CN claimed
EP-1161565-B1 USE OF SUPERABSORBENT POLYMERS FOR TREATING RAW SKINS, CORRESPONDING COMPOSITIONS AND METHODS AND RESULTING TREATED SKINS SNF SA (FR) 2009-10-28 EP claimed
CN-101013080-A Sheath liquid for particle analyzer, method of preparing sheath liquid and particle analytic method using the sheath liquid SYSMEX CORP (JP) 2007-08-08 CN claimed
EP-1578826-B1 SYNTHETIC MATERIAL DISPERSIONS AMI AGROLINZ MELAMINE INT GMBH (AT) 2007-06-20 EP claimed
US-20060173102-A1 Synthetic material dispersions AMI-AGROLINZ MELAMINE INTERNATIONAL GMBH (AT) 2006-08-03 US claimed
EP-1294561-B1 FIBRE COMPOSITES WITH EXCELLENT DIMENSIONAL STABILITY, WEATHER RESISTANCE AND FLAMEPROOFING PROPERTIES AMI AGROLINZ MELAMINE INT GMBH (AT) 2005-04-06 EP claimed
US-20260103885-A1 Cementitious Panels with Swellable Materials and Methods of Providing a Moisture or Water Barrier in Cementitious Panels Using Swellable Materials GOLD BOND BUILDING PRODUCTS LLC (US) 2026-04-16 US disclosed
US-20250288972-A1 Nanoporous Superabsorbent Particles with Low Non-Solvent Levels KIMBERLY-CLARK WORLDWIDE, INC. 2025-09-18 US disclosed
US-12337297-B2 Nanoporous superabsorbent particles with low non-solvent levels KIMBERLY-CLARK WORLDWIDE, INC. (US) 2025-06-24 US disclosed
WO-2025129030-A1 PROCESS FOR PRODUCING ABSORBENT SUBSTRATES KIMBERLY-CLARK WORLDWIDE, INC. (US) 2025-06-19 WO disclosed
US-20250052057-A1 Cementitious Panels with Swellable Materials and Methods of Providing a Moisture or Water Barrier in Cementitious Panels Using Swellable Materials BANK OF AMERICA, N.A., AS COLLATERAL AGENT 2025-02-13 US disclosed
US-12194435-B2 Nanoporous superabsorbent particles KIMBERLY-CLARK WORLDWIDE, INC. (US) 2025-01-14 US disclosed
EP-0690885-A1 METHOD OF PRODUCTION OF COPOLYMERS OF POLYAMINO ACIDS Calwood Chemical Industries, Inc. (US) 1996-01-10 EP disclosed
EP-0690885-A4 METHOD OF PRODUCTION OF COPOLYMERS OF POLYAMINO ACIDS SRCHEM INC (US) 1995-11-15 EP disclosed
WO-1994021710-A1 METHOD OF PRODUCTION OF COPOLYMERS OF POLYAMINO ACIDS SRCHEM, INC. (US) 1994-09-29 WO disclosed
US-5292858-A Method of production of copolymers of polyamino acids SRCHEM INCORPORATED (US) 1994-03-08 US disclosed
US-4076663-A POLYMERIZING WITH UNSATURATED MONOMER, CROSSLINKING, HYDROLYZING SANYO CHEMICAL INDUSTRIES, LTD. (JA) 1978-02-28 US disclosed
US-4008126-A Immobilization of proteins by in-situ polymerization OWENS-ILLINOIS, INC. (US) 1977-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260103885-A1 Cementitious Panels with Swellable Materials and Methods of Providing a Moisture or Water Barrier in Cementitious Panels Using Swellable Materials DSG1, AQP4, WAPL TSHR 4831/4885TP53 115/4885EGLN1 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.